-
Oseltamivir is Gone, and the Pattern of Anti-influenza Drugs is Reversed!
The latest weekly influenza report of the National Influenza Center on June 17 (6.6-6.12) showed that the proportion of influenza-like cases (ILI%) am...
2022-06-23 18:07 -
Market Comparison Before and after the 3rd Batch of Nationally Sourced Hypoglycemic Drug Metformin
As a well-known hypoglycemic drug, metformin plays an important role in the field of diabetes treatment. It is the widest and largest variety in the f...
2022-06-23 15:24 -
AstraZeneca and Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib
Recently, AstraZeneca (AstraZeneca) and Merck & Co. (MSD) jointly announced the results of the Phase 3 PROpel clinical trial of its PARP inhibitor ola...
2022-06-23 14:34 -
Phase III Study of AstraZeneca's Innovative Therapy was Successful! A Listing Application Will be Su...
On June 21, AstraZeneca announced that the Phase III NEURO-TTRansform study of eplontersen in hereditary transthyretin-mediated amyloid polyneuropathy...
2022-06-21 18:03 -
In 2021, India's Ibuprofen API Export Volume and Price will Fall
Ibuprofen is an arylpropionic acid anti-inflammatory, analgesic, analgesic, and anti-rheumatic drug with significant anti-inflammatory, analgesic, and...
2022-06-20 16:49 -
Merck to Acquire ADC Leader Seagen
Merck is evaluating the possibility of acquiring Seagen, according to the Wall Street Journal. As soon as the news came out, Seagen rose nearly 18% af...
2022-06-20 14:01 -
AstraZeneca is Considering Buying Its Partner Mereo BioPharma
According to the British "Times" report, there are rumors that AstraZeneca is considering the acquisition of its London-based partner Mereo BioPharma....
2022-06-20 13:58 -
The Third-generation EGFR Inhibitor 'Ametinib' is Filed for Listing in the UK
On June 15, Hansoh Pharma announced that its overseas partner, EQRx, has submitted a New Drug Application (MAA) for the third-generation EGFR inhibito...
2022-06-17 16:59 -
UK MHRA Accepts Marketing Application for Almetinib
On June 14, EQRx, Inc announced that the UK Medicines and Health Products Regulatory Agency (MHRA) has accepted a Marketing Authorization Application ...
2022-06-16 13:48 -
AstraZeneca's AZD8205 Clinical Trial Application Approved
On June 14, CDE's official website showed that AstraZeneca's clinical trial application for AZD8205 was approved for the treatment of advanced or meta...
2022-06-15 11:22
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
